Ovation and GTC expect to develop ATryn as a supplement to restore heparin responsivenes in heparin resistant patients. When LEO decides to join Ovation in this field does LEO than have to pay GTC for this new application of ATryn, for instance do they have to pay an initial payment?? Could you led in some light on this matter Dew?